Good Sense all day allergy
- Product NDC
- 68788-4023
- 11-digit product format
- 687884023
- Labeler code
- 68788
- Product ID
- 68788-4023_0827643a-29b8-487a-a158-28976d672d4d
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Cetirizine Hydrochloride
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Preferred Pharmaceuticals Inc
- Application
- ANDA078336
- Marketing category
- ANDA
- Marketing start
- 2025-09-12
- Substance
- CETIRIZINE HYDROCHLORIDE
- Active strength
- 10 mg/1
- Pharmacologic classes
- Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Good Sense all day allergy
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| CETIRIZINE HYDROCHLORIDE | 10 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 64O047KTOA |
| Rxcui | 1014678 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 68788-4023-3 | Good Sense all day allergy | 30 in 1 BOTTLE | TABLET, FILM COATED | 30 | | 1 |
| 68788-4023-6 | Good Sense all day allergy | 60 in 1 BOTTLE | TABLET, FILM COATED | 60 | | 1 |
| 68788-4023-9 | Good Sense all day allergy | 90 in 1 BOTTLE | TABLET, FILM COATED | 90 | | 1 |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|
| 68788-4023-3 | 68788402303 | 30 TABLET, FILM COATED in 1 BOTTLE (68788-4023-3) | 2025-09-12 | No | No | Current |
| 68788-4023-6 | 68788402306 | 60 TABLET, FILM COATED in 1 BOTTLE (68788-4023-6) | 2025-09-12 | No | No | Current |
| 68788-4023-9 | 68788402309 | 90 TABLET, FILM COATED in 1 BOTTLE (68788-4023-9) | 2025-09-12 | No | No | Current |